126 related articles for article (PubMed ID: 28401563)
1. Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
Gupta S; Mola G; Ramsay P; Jenkins G; Stein W; Bolnga J; Black K
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):213-218. PubMed ID: 28401563
[TBL] [Abstract][Full Text] [Related]
2. Impact of the contraceptive implant on maternal and neonatal morbidity and mortality in rural Papua New Guinea: a retrospective observational cohort study.
Gupta S; Ramsay P; Mola G; McGeechan K; Bolnga J; Kelly-Hanku A; Black KI
Contraception; 2019 Jul; 100(1):42-47. PubMed ID: 30898659
[TBL] [Abstract][Full Text] [Related]
3. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
5. New Zealand women's experience during their first year of Jadelle® contraceptive implant.
Roke C; Roberts H; Whitehead A
J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370
[TBL] [Abstract][Full Text] [Related]
6. Implant contraception in Singaporean women: one decade of experience in KK Women's and Children's Hospital.
Kang W; Tan KH
Singapore Med J; 2004 Oct; 45(10):482-6. PubMed ID: 15455169
[TBL] [Abstract][Full Text] [Related]
7. Impact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom.
Davie JE; Walling MR; Mansour DJ; Bromham D; Kishen M; Fowler P
Clin Ther; 1996; 18(1):150-9. PubMed ID: 8851460
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
Haugen MM; Evans CB; Kim MH
J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
[TBL] [Abstract][Full Text] [Related]
10. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
11. Immediate versus delayed postpartum use of levonorgestrel contraceptive implants: a randomized controlled trial in Uganda.
Averbach S; Kakaire O; Kayiga H; Lester F; Sokoloff A; Byamugisha J; Dehlendorf C; Steinauer J
Am J Obstet Gynecol; 2017 Nov; 217(5):568.e1-568.e7. PubMed ID: 28610898
[TBL] [Abstract][Full Text] [Related]
12. Acceptance, efficacy, and side effects of Norplant implants in four counties in north China.
Tu P; Qiu S; Fang H; Smith HL
Stud Fam Plann; 1997 Jun; 28(2):122-31. PubMed ID: 9216032
[TBL] [Abstract][Full Text] [Related]
13. Long-acting contraceptive options.
Kaunitz AM
Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
15. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
[TBL] [Abstract][Full Text] [Related]
17. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Weisberg E; Bateson D; McGeechan K; Mohapatra L
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
[TBL] [Abstract][Full Text] [Related]
18. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive continuation rates in Papua New Guinea.
Townsend PK
P N G Med J; 1983 Jun; 26(2):114-21. PubMed ID: 6593954
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
